Company Filing History:
Years Active: 1995-2000
Title: The Innovations of Robert G Johnson
Introduction
Robert G Johnson is a notable inventor based in Rosemont, PA (US). He has made significant contributions to the field of biochemistry, particularly in the area of human adenosine receptors. With a total of 5 patents to his name, Johnson's work has had a profound impact on scientific research and pharmaceutical development.
Latest Patents
Johnson's latest patents focus on recombinant human adenosine receptors A1, A2a, A2b, and A3. These inventions have been prepared using cDNA cloning and polymerase chain reaction techniques. The patents also detail expression systems for these receptors and assays utilizing these systems. The recombinant adenosine receptors can be employed in assays to identify and evaluate entities that bind to or enhance binding to adenosine receptors.
Career Highlights
Johnson is currently associated with Merck & Co., Inc., where he continues to advance his research in the field. His work has been instrumental in understanding the mechanisms of adenosine receptors, which play a crucial role in various physiological processes.
Collaborations
Throughout his career, Johnson has collaborated with esteemed colleagues, including Marlene A Jacobson and Christopher A Salvatore. These collaborations have further enriched his research and contributed to the success of his inventions.
Conclusion
Robert G Johnson's innovative work in the field of human adenosine receptors exemplifies the importance of scientific research in developing new therapeutic approaches. His contributions continue to influence the pharmaceutical industry and enhance our understanding of biochemistry.